aod9604 clinical trial obesity results AOD-9604 Peptide AOD9604 | HLabs

Looking ahead, the future of therapeutic peptides is promising

In some embodiments, the invention encompasses a method of providing muscular therapy by contacting a cell expressing NNMT with a NNMT inhibitor (such as a cation of Formula I or IA, or otherwise disclosed herein) and one or more chemical entities (e.g., nicotinamide riboside, nicotinamide mononucleotide) that increases intracellular NAD+ levels to provide muscular therapy

This duration balances therapeutic benefits with manageable treatment commitment and cost considerations

However, on average patients will see a response from the vitamin B12 injections around 48 to 72 hours after, with brisk production of new red blood cells